CVS Settles US Justice Department Case Over Opioid Prescriptions for $315 Million

3-line summary

• CVS Health agreed to pay the US Department of Justice $315 million to settle allegations it improperly filled medically unnecessary prescriptions for addictive opioid painkillers, the DOJ announced Tuesday, October 13, according to Investing.com. The allegations centered on Controlled Substances Act violations in dispensing opioids and other narcotic painkillers since October 2013, followed by False Claims Act violations for billing federal health programs including Medicare for those prescriptions.
• The DOJ first disclosed the case in 2024, saying it would hold CVS accountable; this settlement resolves it. As part of a related agreement with the DEA, CVS will set up procedures to monitor and report suspected illegal dispensing within its pharmacies and evaluate physicians suspected of improper prescribing. CVS said it disagreed with the DOJ's allegations and did not admit wrongdoing in the settlement.

This summary is our own processing of the source article; see the source link below for full context.